Literature DB >> 30368739

Rifabutin induced multinucleated hepatocytes in rats: an overview with future prospects.

Amr Ahmed El-Arabey1, Mohnad Abdalla2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30368739     DOI： 10.1007/s10096-018-3411-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

1.  Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain.

Authors:  K Farid Ahmad; Ari Melnick; Stuart Lax; Denis Bouchard; Jun Liu; Chih-Li Kiang; Sebastian Mayer; Shinichiro Takahashi; Jonathan D Licht; Gilbert G Privé
Journal:  Mol Cell       Date:  2003-12       Impact factor: 17.970

Review 2.  Cellular Senescence and the Biology of Aging, Disease, and Frailty.

Authors:  Nathan K LeBrasseur; Tamara Tchkonia; James L Kirkland
Journal:  Nestle Nutr Inst Workshop Ser       Date:  2015-10-20

Review 3.  Antimicrobial activity of rifabutin.

Authors:  C M Kunin
Journal:  Clin Infect Dis       Date:  1996-04       Impact factor: 9.079

4.  Multinucleated hepatocytes induced by rifabutin in rats.

Authors:  G Scampini; A Nava; A J Newman; P Della Torre; G Mazué
Journal:  Toxicol Pathol       Date:  1993       Impact factor: 1.902

5.  Male-specific hepatic Bcl6: growth hormone-induced block of transcription elongation in females and binding to target genes inversely coordinated with STAT5.

Authors:  Rosana D Meyer; Ekaterina V Laz; Ting Su; David J Waxman
Journal:  Mol Endocrinol       Date:  2009-10-01

Review 6.  Rifabutin: where do we stand in 2016?

Authors:  Yoann Crabol; Emilie Catherinot; Nicolas Veziris; Vincent Jullien; Olivier Lortholary
Journal:  J Antimicrob Chemother       Date:  2016-03-23       Impact factor: 5.790

7.  Male-dominant activation of rat renal organic anion transporter 1 (Oat1) and 3 (Oat3) expression by transcription factor BCL6.

Authors:  Waja Wegner; Birgitta Christina Burckhardt; Gerhard Burckhardt; Maja Henjakovic
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

8.  The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain.

Authors:  Sian E Evans; Benjamin T Goult; Louise Fairall; Andrew G Jamieson; Paul Ko Ferrigno; Robert Ford; John W R Schwabe; Simon D Wagner
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.